303 related articles for article (PubMed ID: 11571465)
1. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.
Goldstein DR; Thomas JM; Kirklin JK; George JF
Transplantation; 2001 Sep; 72(5):954-6. PubMed ID: 11571465
[TBL] [Abstract][Full Text] [Related]
2. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.
Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644
[TBL] [Abstract][Full Text] [Related]
3. Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow.
Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
Transplantation; 2000 Mar; 69(5):1020-2. PubMed ID: 10755572
[TBL] [Abstract][Full Text] [Related]
4. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
5. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
7. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
Masli S; De Fazio SR; Gozzo JJ
Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
[TBL] [Abstract][Full Text] [Related]
8. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of adult skin allograft survival by cotransplantation of neonatal skin in antilymphocyte serum and donor bone marrow cell-treated mice.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1990 Dec; 50(6):911-4. PubMed ID: 2256160
[TBL] [Abstract][Full Text] [Related]
10. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
Wong W; Morris PJ; Wood KJ
Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
[TBL] [Abstract][Full Text] [Related]
12. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
13. Effect of asialofetuin on prolongation of skin allograft survival by donor bone marrow cells.
Khouri W; Masli S; De Fazio SR; Gozzo JJ
Transplantation; 1994 Feb; 57(3):440-6. PubMed ID: 7509090
[TBL] [Abstract][Full Text] [Related]
14. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842
[TBL] [Abstract][Full Text] [Related]
16. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
17. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
18. Prolonged adult skin allograft survival as a result of cotransplantation with neonatal tissue. The requirement for antigen sharing between graft and cotransplant.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1992 Dec; 54(6):955-8. PubMed ID: 1465789
[TBL] [Abstract][Full Text] [Related]
19. Importance of natural killer cells in the rejection of hamster skin xenografts.
Gourlay WA; Chambers WH; Monaco AP; Maki T
Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
[TBL] [Abstract][Full Text] [Related]
20. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
